List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 46 studies with search of: "Thrombophilia"
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Completed Thrombophilia and Migraine, Are They Related?
Conditions: Migraine;   Thrombosis;   Thrombophilia
Intervention: Procedure: Blood tests
2 Recruiting TIPPS: Thrombophilia in Pregnancy Prophylaxis Study
Conditions: Pregnancy;   Thrombophilia;   Pregnancy Complications
Interventions: Drug: dalteparin sodium 5,000 IU prefilled syringes (antenatal);   Drug: dalteparin sodium (after delivery - Control group)
3 Completed Thrombophilia and Thyroid Autoimmunity in Implantation Failure and Recurrent Miscarriage
Condition: Thrombophilia, Thyroid Autoimmunity
Intervention: Procedure: blood analysis
4 Active, not recruiting Effect of DT56a (Femarelle) on the Coagulation System in the Treatment of Postmenopausal Women
Conditions: Menopause;   Thrombophilia
Intervention: Dietary Supplement: DT56a (Femarelle) [Se-cure pharmaceuticals, Dalton, Israel]
5 Recruiting A Comparison of Sequential Compression Devices and Foot Pumps in the Obstetric Population
Condition: Thrombophilia
Interventions: Device: Kendall A-V foot impulse pump, model 6060;   Device: Kendall sequential compression device, model 9525
6 Recruiting Pharmacokinetics of Low Molecular Weight and Unfractionated Heparin in Pregnancy
Conditions: Recurrent Pregnancy Loss,;   Fetal Demise;   Abortion, Habitual;   Antiphospholipid Antibodies;   Inherited Thrombophilia
Intervention:
7 Recruiting Frankfurt Thrombophilia Registry
Condition: Venous Thromboembolism
Intervention: Other: Blood sampling
8 Completed Hypercoagulability After Breast Cancer Surgery
Conditions: Breast Cancer;   Blood Coagulation Disorders
Intervention: Procedure: Blood collection (pre and postoperative): plasma coagulation parameters
9 Recruiting The Effect of Reduced Dose of Enoxaparin on the Outcomes of Treatment With Enoxaparin
Conditions: Acute Coronary Syndrome;   Venous Thromboembolism;   Atrial Fibrillation;   Hypercoagulability
Intervention:
10 Recruiting Hypercoagulability and Thromboembolic Risk in Patients With Malignant Disease, Evaluated by Thrombelastograph (TEG®)
Condition: Cancer
Intervention:
11 Terminated Fetal Loss in Women With Unprovoked Thromboembolism (FLUTE)
Conditions: Venous Thromboembolism;   Fetal Death
Intervention: Other: Thrombophilia Testing
12 Active, not recruiting Evaluating the Relationship Between Blood Clotting Disorders, Inflammation, and Obesity in Individuals With Venous Disorders and Post-Thrombotic Syndrome
Conditions: Venous Thrombosis;   Venous Insufficiency
Intervention:
13 Recruiting Safety Monitoring of Patients Having Pulmonary Vein Ablation
Condition: Atrial Fibrillation
Intervention:
14 Completed Detecting Abnormal Blood Clotting in Patients With Metastatic Cancer Undergoing Surgery
Conditions: Thromboembolism;   Unspecified Adult Solid Tumor, Protocol Specific
Interventions: Other: coagulation study;   Other: immunoenzyme technique;   Other: laboratory biomarker analysis;   Other: physiologic testing;   Procedure: study of high risk factors
15 Terminated Safety and Efficacy Study To Compare Uniplas With Cryosupernatant Plasma In Thrombotic Thrombocytopenic Purpura (TTP)
Condition: Thrombotic Thrombocytopenic Purpura (TTP)
Intervention: Drug: Uniplas
16 Completed Recombinant Human Antithrombin (rhAT) in Patients With Hereditary Antithrombin Deficiency Undergoing Surgery or Delivery
Condition: Antithrombin III Deficiency
Intervention: Drug: Recombinant Human Antithrombin
17 Completed Efficacy and Safety Study of Protein C Concentrate in Subjects With Severe Congenital Protein C Deficiency
Condition: Protein C Deficiency
Intervention: Drug: Protein C Concentrate (Human) Vapor Heated
18 Terminated Recombinant Human Antithrombin (ATryn®) in the Treatment of Patients With DIC Associated With Severe Sepsis
Condition: Disseminated Intravascular Coagulation
Intervention: Drug: antithrombin alfa (INN name)
19 Completed Retrospective Study to Capture Dosing and Treatment Outcome Data in Subjects With Severe Congenital Protein C Deficiency Who Were Treated With Protein C Concentrate Under an Emergency Use IND
Condition: Protein C Deficiency
Intervention: Drug: Protein C Concentrate (Human) Vapor Heated
20 Recruiting Safety, Pharmacokinetics and Efficacy of an AT-III Concentrate.
Condition: Antithrombin III Deficiency
Intervention: Drug: Plasma-derived AT-III concentrate

Previous Page Studies Shown (1-20) Next Page (21-40)
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
RSS Feeds for studies found by your search that were:
  First received in the last 14 days,  
  Last updated (includes received) in the last 30 days
  Download Options




Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services